Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,855 | 60,335 | 102,055 | 134,786 | 166,010 |
| Marketable Securities | 67,951 | 92,791 | 55,143 | 44,781 | 34,264 |
| Receivables | 3,311 | 8,559 | 8,169 | 7,803 | 59 |
| Other current assets | 3,292 | 4,650 | 5,438 | 3,389 | 10,699 |
| TOTAL | $141,409 | $166,335 | $189,241 | $208,779 | $225,604 |
| Non-Current Assets | |||||
| PPE Net | 11,607 | 11,978 | 15,768 | 14,942 | 15,011 |
| Intangibles | 4,671 | 4,671 | 4,671 | 4,671 | 4,671 |
| Other Non-Current Assets | 1,209 | 1,421 | 2,425 | 2,894 | 2,806 |
| TOTAL | $17,487 | $18,070 | $22,864 | $22,507 | $22,488 |
| Total Assets | $158,896 | $184,405 | $212,105 | $231,286 | $248,092 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,711 | 3,659 | 4,290 | 4,290 | 4,290 |
| Accounts payable and accrued liabilities | 1,903 | 7,026 | 4,556 | 3,887 | 3,578 |
| Accrued Expenses | 23,615 | 19,685 | 14,755 | 12,014 | 8,500 |
| Other current liabilities | 810 | 8,487 | 4,422 | 4,127 | 4,798 |
| TOTAL | $34,036 | $43,839 | $36,966 | $40,083 | $41,485 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 125 | 566 | 1,639 | 2,711 |
| Deferred Revenues | 4,997 | 4,982 | 8,900 | 15,732 | 16,290 |
| Other Non-Current Liabilities | 17,708 | 19,067 | 365 | 358 | 353 |
| TOTAL | $67,982 | $70,723 | $55,785 | $50,806 | $52,759 |
| Total Liabilities | $102,018 | $114,562 | $92,751 | $90,889 | $94,244 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,304 | 53,243 | 52,959 | 51,931 | 51,804 |
| Common Shares | 53 | 53 | 52 | 52 | 52 |
| Retained earnings | -473,561 | -458,212 | -392,876 | -366,208 | -347,310 |
| Other shareholders' equity | -3 | 10 | 594 | 436 | -178 |
| TOTAL | $56,878 | $69,843 | $119,354 | $140,397 | $153,848 |
| Total Liabilities And Equity | $158,896 | $184,405 | $212,105 | $231,286 | $248,092 |